Instructions for Komfoderm (Methylprednisolone aceponate) ointment
Active substances Komfoderm
Methylprednisolone aceponate
Release Form:
Ointment
Structure Komfoderm:
100 g of methyl prednisolone aceponate (per 100% substance) 100 mg. Auxiliary substances: sorbitol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, sodium hydrophosphate dodecahydrate, ethanol 96%, sodium saccharinate, strawberry flavoring (liquid essence "Strawberry"), purified water. 100 ml - bottles of dark glass (1) complete with a measuring spoon or cup - cardboard packs.
Pharmacological effect:
Pharmacokinetics
Testimony Komfoderm:
- Inflammatory skin diseases, sensitive to therapy with topical glucocorticosteroids:
- atopic dermatitis, neurodermitis, childhood eczema;
- True eczema;
- microbial eczema;
- Professional eczema;
- Simple contact dermatitis;
- allergic (contact) dermatitis;
- dyshydrotic eczema.
Contraindications:
Applied externally 1 time/day with a thin layer on the affected area, rubbing slightly. Possible use with occlusive bandage. Usually, the course of treatment is not more than 12 weeks for adults, and no more than 4 weeks for children. Several therapy courses are possible during the year Komfoderm.
Use in pregnancy and breastfeeding
It is not recommended Komfoderm to use in the presence of pink eels on the face. In bacterial dermatoses or dermatomycoses, concurrent therapy with antibacterial or antifungal agents is required. Physical Komfoderm therapy should not be performed at the same time. Use with particular caution in pregnancy. Avoid eye contact and use on extensive skin surfaces.
Side effects Komfoderm:
Specific skin lesions (tuberculosis, syphilis, chickenpox), skin responses to vaccination, viral diseases.
Special instructions Komfoderm:
Specific skin lesions (tuberculosis, syphilis, chickenpox), skin responses to vaccination, viral diseases.
